[HTML][HTML] The atypical mechanosensitive microRNA-712 derived from pre-ribosomal RNA induces endothelial inflammation and atherosclerosis

DJ Son, S Kumar, W Takabe, C Woo Kim, CW Ni… - Nature …, 2013 - nature.com
DJ Son, S Kumar, W Takabe, C Woo Kim, CW Ni, N Alberts-Grill, IH Jang, S Kim, W Kim…
Nature communications, 2013nature.com
MicroRNAs (miRNAs) regulate cardiovascular biology and disease, but the role of flow-
sensitive microRNAs in atherosclerosis is still unclear. Here we identify miRNA-712 (miR-
712) as a mechanosensitive miRNA upregulated by disturbed flow (d-flow) in endothelial
cells, in vitro and in vivo. We also show that miR-712 is derived from an unexpected source,
pre-ribosomal RNA, in an exoribonuclease-dependent but DiGeorge syndrome critical
region 8 (DGCR8)-independent manner, suggesting that it is an atypical miRNA …
Abstract
MicroRNAs (miRNAs) regulate cardiovascular biology and disease, but the role of flow-sensitive microRNAs in atherosclerosis is still unclear. Here we identify miRNA-712 (miR-712) as a mechanosensitive miRNA upregulated by disturbed flow (d-flow) in endothelial cells, in vitro and in vivo. We also show that miR-712 is derived from an unexpected source, pre-ribosomal RNA, in an exoribonuclease-dependent but DiGeorge syndrome critical region 8 (DGCR8)-independent manner, suggesting that it is an atypical miRNA. Mechanistically, d-flow-induced miR-712 downregulates tissue inhibitor of metalloproteinase 3 (TIMP3) expression, which in turn activates the downstream matrix metalloproteinases (MMPs) and a disintegrin and metalloproteases (ADAMs) and stimulate pro-atherogenic responses, endothelial inflammation and permeability. Furthermore, silencing miR-712 by anti-miR-712 rescues TIMP3 expression and prevents atherosclerosis in murine models of atherosclerosis. Finally, we report that human miR-205 shares the same ‘seed sequence’ as murine-specific miR-712 and also targets TIMP3 in a flow-dependent manner. Targeting these mechanosensitive ‘athero-miRs’ may provide a new treatment paradigm in atherosclerosis.
nature.com